標(biāo)題: Titlebook: HPV Infection in Head and Neck Cancer; Wojciech Golusiński,C. René Leemans,Andreas Dietz Book 2017 Springer International Publishing Switz [打印本頁(yè)] 作者: 灰塵 時(shí)間: 2025-3-21 16:32
書目名稱HPV Infection in Head and Neck Cancer影響因子(影響力)
書目名稱HPV Infection in Head and Neck Cancer影響因子(影響力)學(xué)科排名
書目名稱HPV Infection in Head and Neck Cancer網(wǎng)絡(luò)公開(kāi)度
書目名稱HPV Infection in Head and Neck Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱HPV Infection in Head and Neck Cancer被引頻次
書目名稱HPV Infection in Head and Neck Cancer被引頻次學(xué)科排名
書目名稱HPV Infection in Head and Neck Cancer年度引用
書目名稱HPV Infection in Head and Neck Cancer年度引用學(xué)科排名
書目名稱HPV Infection in Head and Neck Cancer讀者反饋
書目名稱HPV Infection in Head and Neck Cancer讀者反饋學(xué)科排名
作者: configuration 時(shí)間: 2025-3-21 22:30
https://doi.org/10.1007/978-3-642-33603-4bset of head and neck cancers (HNCs). In this chapter, epidemiologic-related topics on HNCs are reviewed: (i) HPV-attributable fractions and HPV-type distributions by different anatomical HNC sites, using not only HPV DNA but other more specific markers of causality; (ii) an update of the HPV-relate作者: Seminar 時(shí)間: 2025-3-22 00:26
nings of the upper aerodigestive tract. These tumors develop either by exogenous carcinogen exposure (smoking, alcohol drinking) or by human papillomavirus (HPV) infection, particularly those in the oropharynx (OPSCC). HPV-positive (HPV+ve) and HPV-negative (HPV-ve) OPSCC are considered different di作者: lactic 時(shí)間: 2025-3-22 05:03 作者: MOTIF 時(shí)間: 2025-3-22 10:47 作者: 先行 時(shí)間: 2025-3-22 13:07 作者: plasma 時(shí)間: 2025-3-22 17:34
https://doi.org/10.1007/978-1-349-22523-1e literature around HPV testing and a large number of proprietary HPV tests, which makes the field difficult to navigate. This review provides a concise contemporary overview of the evidence around HPV testing in head and neck cancer and signposts key publications, guideline documents and the most c作者: CLAN 時(shí)間: 2025-3-22 21:38 作者: 強(qiáng)所 時(shí)間: 2025-3-23 05:05 作者: 愉快嗎 時(shí)間: 2025-3-23 08:14
https://doi.org/10.1007/978-3-319-40286-4factors, patient factors, treatment factors, and the wish of the patient. This symposium article is summarizing the information on HPV (p16) in the context of decision making in SCCHN patients with locoregionally advanced disease and those with recurrent/metastatic disease. The literature data sugge作者: 蛙鳴聲 時(shí)間: 2025-3-23 13:26 作者: 值得尊敬 時(shí)間: 2025-3-23 13:54
https://doi.org/10.1007/978-1-349-16048-8avorable HPV-positive OPC and the high rates of acute and late treatment-related side effects, de-escalation strategies have to be considered. In this chapter, the potential benefit of a number of de-escalation strategies is described, including of replacement of concurrent chemotherapy by cetuximab作者: GROUP 時(shí)間: 2025-3-23 20:40
https://doi.org/10.1007/978-981-15-6735-3me for patients suffering from p16/HPV16-positive oropharyngeal squamous cell carcinoma of head and neck (OHNSCC). These observations are comprehensively addressed, but the reader has to keep in mind that none of the currently discussed data result from prospective controlled trials addressing the H作者: 食品室 時(shí)間: 2025-3-23 23:28
https://doi.org/10.1007/978-1-4612-5628-1access to these tumours is often challenging due to the anatomic localization. For this reason, such tumours were traditionally managed with open surgical techniques, usually involving a mandibulotomy, to provide better visualization and access to the oropharynx, followed by free-flap reconstruction作者: 疲憊的老馬 時(shí)間: 2025-3-24 06:06
The Human Toll of the Kashmir Conflictilloma virus (HPV) driven disease (.). While the outcomes of patients with HPV-positive OPSCC are dramatically improved compared to HPV-negative OPSCC, treatment failures do occur. The result is an inevitable rise in the incidence of recurrent OPSCC. Since the majority of incident OPSCC cases are tr作者: Commission 時(shí)間: 2025-3-24 08:12 作者: 狗窩 時(shí)間: 2025-3-24 13:06
Epidemiology of HPV-Positive Tumors in Europe and in the Worldbset of head and neck cancers (HNCs). In this chapter, epidemiologic-related topics on HNCs are reviewed: (i) HPV-attributable fractions and HPV-type distributions by different anatomical HNC sites, using not only HPV DNA but other more specific markers of causality; (ii) an update of the HPV-relate作者: MAIZE 時(shí)間: 2025-3-24 15:30
Molecular Patterns and Biology of HPV-Associated HNSCCnings of the upper aerodigestive tract. These tumors develop either by exogenous carcinogen exposure (smoking, alcohol drinking) or by human papillomavirus (HPV) infection, particularly those in the oropharynx (OPSCC). HPV-positive (HPV+ve) and HPV-negative (HPV-ve) OPSCC are considered different di作者: FAWN 時(shí)間: 2025-3-24 19:49
HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequenceinating in the oropharynx. The key events in high-risk HPV (HRHPV)-associated neoplastic progression include persistent infection, deregulated expression of virus early genes in basal epithelial cells, local immune suppression and the accumulation of chromosomal alterations. Evidence for these event作者: Subdue 時(shí)間: 2025-3-25 01:27
Risk Factors for Oral Infection with Human Papillomavirusrs arises in the oropharyngeal region, and at present, the infection of the human papilloma type 16 is the major cause of the oropharyngeal cancer development. Patients with HPV DNA-positive tumors have been shown to be younger in age and are less likely to have a history of tobacco smoking or alcoh作者: NORM 時(shí)間: 2025-3-25 06:57 作者: 付出 時(shí)間: 2025-3-25 11:32
HPV Testing of Head and Neck Cancer in Clinical Practicee literature around HPV testing and a large number of proprietary HPV tests, which makes the field difficult to navigate. This review provides a concise contemporary overview of the evidence around HPV testing in head and neck cancer and signposts key publications, guideline documents and the most c作者: 方便 時(shí)間: 2025-3-25 13:56 作者: cumulative 時(shí)間: 2025-3-25 16:26
Tumor Staging and HPV-Related Oropharyngeal Cancerd for Human papillomavirus (HPV)-related OSCC. Patients with HPV-positive tumors have improved prognosis, despite presenting at advanced stages. These shortcomings of the current staging system have been identified in single- and multi-institutional trials. Patients with HPV related OSCC typically p作者: Fulsome 時(shí)間: 2025-3-25 23:08 作者: 培養(yǎng) 時(shí)間: 2025-3-26 00:51 作者: 協(xié)奏曲 時(shí)間: 2025-3-26 07:13 作者: 配置 時(shí)間: 2025-3-26 10:21 作者: miracle 時(shí)間: 2025-3-26 15:18
The Role of Conventional Surgery in Oropharyngeal Canceraccess to these tumours is often challenging due to the anatomic localization. For this reason, such tumours were traditionally managed with open surgical techniques, usually involving a mandibulotomy, to provide better visualization and access to the oropharynx, followed by free-flap reconstruction作者: Senescent 時(shí)間: 2025-3-26 20:18 作者: Project 時(shí)間: 2025-3-27 00:03 作者: neutralize 時(shí)間: 2025-3-27 04:54 作者: Orchiectomy 時(shí)間: 2025-3-27 05:26 作者: Arrhythmia 時(shí)間: 2025-3-27 10:21 作者: 羽毛長(zhǎng)成 時(shí)間: 2025-3-27 16:35
HPV in Head and Neck Cancer—30?Years of Historytion were the first to propose the HPV involvement in a subgroup of head and neck cancers. Brandsma and Abramson demonstrated HPV16 DNA in tonsillar SCCs in 1989. Since the early 2000s, HPV research of head and neck squamous cell carcinomas (HNSCC) has made impressive progress, confirming that the s作者: homocysteine 時(shí)間: 2025-3-27 21:11 作者: GROUP 時(shí)間: 2025-3-28 00:52 作者: 無(wú)可非議 時(shí)間: 2025-3-28 02:59
0080-0015 and nonsurgical treatment as well as vaccination.Describes pThis book is exceptional in presenting an interdisciplinary approach to the subject of human papillomavirus (HPV) infection in the context of head and neck cancer. Leading experts in the field discuss the epidemiology and molecular biology 作者: ANTIC 時(shí)間: 2025-3-28 08:13
https://doi.org/10.1007/978-3-030-33912-8e compared to those with HPV-negative tumors. In fact, as a surrogate of HPV infection for clinical studies, an immunohistochemical expression of p16 protein is used. In the following chapter, the spectrum of squamous cell carcinomas variants with indication of the percentage cases with proved HPV infection will be presented.作者: CLASP 時(shí)間: 2025-3-28 12:27
https://doi.org/10.1007/978-3-642-33603-4al behavior, and other related factors such as tonsillectomy performance. This information is essential in order to understand the burden of the disease and its dynamics and changing patterns, as well as for planning and assessment of the potential impact of HPV-based preventive strategies for HNCs.作者: 北京人起源 時(shí)間: 2025-3-28 18:15
, despite their generally advanced stage at presentation. In general, HNSCCs develop in?precancerous mucosal changes, and the apparent lack of precancerous HPV+ve mucosal changes is therefore remarkable. In this Chapter, head and neck carcinogenesis is discussed and the molecular differences between HPV+ve and HPV-ve tumors are outlined.作者: RALES 時(shí)間: 2025-3-28 21:52 作者: 昏睡中 時(shí)間: 2025-3-29 01:14 作者: 反省 時(shí)間: 2025-3-29 04:14 作者: Confound 時(shí)間: 2025-3-29 08:38 作者: 宏偉 時(shí)間: 2025-3-29 15:26 作者: HERTZ 時(shí)間: 2025-3-29 17:46 作者: 拍下盜公款 時(shí)間: 2025-3-29 23:40
Variation of HPV Subtypes with Focus on HPV-Infection and Cancer in the Head and Neck Regionn subtypes are essentially heterogeneous in efficacy triggering neoplastic transformation and cancer development. This could explain differences in the clinical course of HPV-driven head and neck cancer.作者: MOT 時(shí)間: 2025-3-30 00:09
Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCCHPV in the R/M situation are still scarce. Due to the rising incidence of HPV-associated cancers, the number of R/M HPV+ carcinomas is also expected to rise. This chapter therefore aims to give an overview of the current knowledge concerning the role of HPV as a prognostic and predictive marker in recurrent or metastatic HNSCC.作者: 察覺(jué) 時(shí)間: 2025-3-30 07:00
Should We De-escalate the Treatment for HPV-Positive Tumors?clinical reports and lack of data of prospective trials not mature for routine clinical decision making in 2016. Independent of the currently lacking evidence for HPV-dependent treatment de-escalation, there are some relevant arguments to address this question in ongoing and future trials.作者: Strength 時(shí)間: 2025-3-30 09:28
The Role of Conventional Surgery in Oropharyngeal Cancer dysfunction, in addition to poor cosmetic outcomes. In response, less invasive approaches (Mercante et al. .) have been developed including minimally invasive surgical approaches (chiefly transoral surgery) as well as non-surgical methods, primarily radiotherapy, and chemotherapy (Mercante et al. .).
